Pharmadrug Inc (PHRX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 50 | 26 | 21 | 1,283 | 1,297 |
| Income taxes - deferred | 0 | -1,010 | -190 | -834 | 0 |
| Accounts receivable | -4 | 4 | -57 | 108 | -140 |
| Accounts payable and accrued liabilities | N/A | N/A | 571 | -123 | -88 |
| Other Working Capital | -303 | 294 | 687 | -132 | -252 |
| Other Operating Activity | -500 | 14 | -3,290 | -4,428 | -2,230 |
| Operating Cash Flow | $-757 | $-672 | $-2,257 | $-4,125 | $-1,414 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 0 | -18 |
| Net Acquisitions | 0 | 742 | -12 | 309 | 2,176 |
| Purchase Of Investment | N/A | N/A | N/A | 0 | -492 |
| Sale Of Investment | 0 | 253 | 94 | 1,214 | 2,115 |
| Purchase Sale Intangibles | -12 | N/A | N/A | -43 | 0 |
| Other Investing Activity | 0 | 0 | -4 | 0 | 0 |
| Investing Cash Flow | $-12 | $995 | $78 | $1,481 | $3,781 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | -96 | -45 | N/A | N/A |
| Debt Issued | 0 | 100 | 650 | 0 | 250 |
| Debt Repayment | N/A | 0 | -3 | -64 | -2,192 |
| Common Stock Issued | 326 | 0 | 280 | 0 | 200 |
| Other Financing Activity | -4 | 222 | -39 | 841 | 1,874 |
| Financing Cash Flow | $322 | $226 | $843 | $777 | $132 |
| Exchange Rate Effect | -2 | 3 | 387 | 691 | -439 |
| Beginning Cash Position | 560 | 8 | 958 | 2,135 | 74 |
| End Cash Position | 111 | 560 | 9 | 958 | 2,135 |
| Net Cash Flow | $-447 | $549 | $-1,336 | $-1,868 | $2,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | -757 | -672 | -2,257 | -4,125 | -1,414 |
| Capital Expenditure | -12 | N/A | N/A | -43 | -18 |
| Free Cash Flow | -769 | -672 | -2,257 | -4,168 | -1,432 |